EXPRESSION OF PRO-INFLAMMATORY CYTOKINES (IL18, IL33) AT THE LEVEL OF THE MUCOUS MEMBRANE OF THE ENTRANCE PORTAL OF INFECTION IN PERSONS WHO HAVE EXPERIENCED COVID-19 DISEASE



Cite item

Full Text

Abstract

Introduction. The mucous membrane of the upper respiratory tract is the entrance gate for a large number of infections, including the SARS-CoV 2 virus. That is why the main task of the immune system of the mucous membranes of the entrance gate of infection is to maintain respiratory function. High production of proinflammatory cytokines, which play a key role in the development of severe COVID-19 infection, leads to detrimental consequences for all body systems. Their long-term influence can not only aggravate chronic pathologies, but also significantly increase the recovery period, leading to a decrease in the quality of life of patients. Purpose. Therefore, the purpose of this work is to study the expression of IL-18 and IL-33 genes at the level of the mucous membranes of the upper respiratory tract in patients who have had COVID-19 disease. Materials and methods. The present study involved patients who had moderate or severe COVID-19. The control group consisted of relatively healthy individuals. The expression levels of IL-18 and IL-33 were detected using RT-PCR. Results. During the entire period of rehabilitation after suffering from COVID-19, patients showed a tendency to increase the level of IL-18 expression at the level of the mucous membranes of the nasopharynx and oropharynx. The level of IL-33 production was also increased, but varied depending on the location and period of sample collection.  Conclusions. This increase in the level of IL-18 during the rehabilitation period of patients after COVID-19 may be explained by the fact that the virus, by activating glia through olfactory receptor neurons, triggers a powerful immune response and promotes the production of a large number of pro-inflammatory cytokines. On the contrary, overexpression of IL-33 in the late stages of rehabilitation is most likely associated with its ability to restore barrier tissues of the mucous membranes of the upper respiratory tract. Thus, we can conclude that the virus promotes excessive production of pro-inflammatory cytokines, the amount of which increases maximally at the 6th month of rehabilitation after suffering from COVID-19.

About the authors

Nadezhda D. Rasskazova

I. Mechnikov Research Institute of Vaccines and Sera

Author for correspondence.
Email: neonovita@mail.ru
ORCID iD: 0000-0003-0729-5940
SPIN-code: 8940-6505

junior researcher fellow of Laboratory of Molecular Immunology

Russian Federation, 105064 Moscow, Maly Kazenny per., 5A

Natalya D. Abramova

I. Mechnikov Research Institute of Vaccines and Sera

Email: and960911@gmail.com
ORCID iD: 0000-0002-7307-0515
SPIN-code: 1763-8942

Junior Researcher fellow of Laboratory of Molecular Immunology

Russian Federation

Tala D. Soschenko

I. Mechnikov Research Institute of Vaccines and Sera

Email: talasoschenko@mail.ru

laboratory assistant Laboratory of Molecular Immunology

Russian Federation

Ekaterina A. Meremianina

I. Mechnikov Research Institute of Vaccines and Sera, FSBEI FPE "Russian Medical Academy of Continuous Professional Education" MOH Russia.

Email: ekaterina@meremianina.ru
ORCID iD: 0000-0003-4334-1473
SPIN-code: 9721-4839

candidate of medical science, research fellow of Laboratory of Molecular Immunology, I. Mechnikov Research Institute of Vaccines and Sera, Senior Lecturer at the Department of Virology FSBEI FPE "Russian Medical Academy of Continuous Professional Education" MOH Russia.

Russian Federation

Natalia O. Kalyuzhnaya

I. Mechnikov Research Institute of Vaccines and Sera

Email: nat_kalyuzhnaya@mail.ru
ORCID iD: 0000-0002-1668-1846
SPIN-code: 7169-6807

Junior Researcher fellow of Laboratory of Molecular Immunology

Russian Federation

Maksim N. Shatokhin

Russian Medical Academy of Continuous Professional Education, Moscow, Russia

Email: sh.77@mail.ru
ORCID iD: 0000-0002-1285-7357

MD, PhD, Professor, Department of endoscopic urology

Russian Federation

Tatyana A. Zaitseva

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of Russia

Email: zaytseva_t_a@staff.sechenov.ru
ORCID iD: 0000-0001-9205-322X

Ph.D., Associate Professor of the Department of Microbiology, Virology and Immunology named after Academician A.A. Vorobyov, First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of Russia

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Rasskazova N.D., Abramova N.D., Soschenko T.D., Meremianina E.A., Kalyuzhnaya N.O., Shatokhin M.N., Zaitseva T.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies